• FY25 Adjusted EPS of US126.1¢ in upper half of guidance range
• KBU integration complete, synergies target upgraded to $15m
• Pricing actions offset US tariffs, initial increases implemented
• On-market share buyback of up to $200m in FY26

Ansell Limited (ASX:ANN) today announced its financial results for the full year ended 30 June 2025. The company delivered strong top and bottom-line growth in FY25, with Adjusted EPS of US126.1¢ in the upper half of the guidance range. This was driven by solid sales and margin performance in both the Industrial and Healthcare segments. The acquired KBU business integration was completed ahead of schedule, and the synergies target has been upgraded from $10m to $15m by FY27. Pricing actions were successfully implemented to offset the impact of US tariffs, with initial increases rolled out in June 2025 and further increases to follow. Ansell's balance sheet remains strong, with Net Debt/EBITDA of 1.6x. The company also announced an on-market share buyback of up to $200m in FY26. Looking ahead, Ansell expects Adjusted EPS in the range of US133¢ to US145¢ in FY26, with constant currency sales growth and further synergy and productivity savings to support earnings expansion.

Adjusted EPS in the range of US133¢ to US145¢ in FY26, up from US126.1¢ in FY25. Includes ~$7m in incremental KBU net pre-tax cost synergies and ~$3m in incremental APIP savings.

Ansell expects mixed end market conditions, with solid healthcare demand offset by subdued demand in some industrial verticals. The economic effects of higher tariffs in the US remain unclear, but the company anticipates constant currency sales growth from both higher volumes and tariff-related pricing.